Skip to main content

and
  1. No Access

    Article

    Commentary on: “Stereotyped activities produced by amphetamine in several animal species and man.” Psychopharmacologia (1967) 11:300–310

    R. Fog, A. Randrup in Psychopharmacology (2002)

  2. No Access

    Chapter and Conference Paper

    On the State of Knowledge in Neurobiological Psychiatry

    Our present knowledge of neurobiological mechanisms in psychosomatic disorders or in mental disturbances connected with physical illness is practically nil. This reflects the state of knowledge in biological p...

    R. Fog in Interaction Between Mental and Physical Illness (1989)

  3. No Access

    Chapter and Conference Paper

    On Current Research in Affective Disorders

    To give a short review of all the excellent papers of the current research in affective disorders in this volume is not an easy task. A lot of new data have emerged since I gave a similar review 3 years ago (Fog ...

    R. Fog in Psychopharmacology: Current Trends (1988)

  4. No Access

    Chapter and Conference Paper

    The Effect of Dopamine Antagonists in Spontaneous and Tardive Dyskinesia

    Dopamine antagonists are effective in suppressing hyperkinetic symptoms in patients with tardive dyskinesia, spontaneous oral dyskinesia, Huntington’s chorea, and Gilles de la Tourette’s syndrome. These neurol...

    R. Fog in Dyskinesia (1985)

  5. No Access

    Chapter

    Neuroleptic-induced ‘tardive Tourrette’s syndrome’ and neurotoxicity

    Neurological side effects have been associated with neuroleptic drugs since these drugs were introduced in the treatment of psychiatric disorders. Acute dystonia and parkinsonism may be seen in the initial pha...

    R. Fog, H. Pakkenberg in Clinical Pharmacology in Psychiatry (1981)

  6. No Access

    Chapter

    Amphetamines and psychosis

    At the present stage of knowledge it seems reasonable to assume that every normal thought process or normal behaviour has one neuro-biological correlate, and that every abnormal form of function—even if induce...

    Dr I. Munkvad, A. Randrup, R. Fog in Hormones and the Brain (1980)

  7. No Access

    Chapter

    Theoretical and Clinical Aspects of the Tourette Syndrome (Chronic Multiple Tic)

    In three schizophrenic patients long-term neuroleptic treatment induced Tourette-like symptoms. There seems to be a partial overlap in the pathogenesis of Tourette Syndrome and tardive dyskinesia.

    R. Fog, H. Pakkenberg MD in Current Topics in Extrapyramidal Disorders (1980)

  8. No Access

    Chapter

    Stereotyped Behavior and Its Relevance for Testing Neuroleptics

    During the early Sixties it became clear that the characteristic clinical effects of neuroleptics (antimanic, antischizophrenic, neurologic) correlated with their ability to antagonize stereotypies elicited in...

    A. Randrup, B. Kjellberg, E. Schiørring, J. Schell-Krüger, R. Fog in Psychotropic Agents (1980)

  9. No Access

    Article

    Extrapyramidal reactions and amine metabolites in cerebrospinal fluid during haloperidol and clozapine treatment of schizophrenic patients

    8 male schizophrenic patients participated in a double-blind, cross over study of the extrapyramidal side-effects of haloperidol and clozapine (acute dystonia, Parkinsonism and tardive dyskinesia), together wi...

    J. Gerlach, K. Thorsen, R. Fog in Psychopharmacologia (1975)

  10. No Access

    Chapter

    Catecholamines in Activation, Stereotypy, and Level of Mood

    Studies of the effects of psychoactive drugs have contributed much to the present knowledge of the role of catecholamines in behavioral physiology. Since drugs are never completely specific, i.e., no drug acts...

    A. Randrup, I. Munkvad, R. Fog, I. H. Ayhan in Catecholamines and Behavior · 1 (1975)

  11. No Access

    Article

    Short-term effect of perphenazine enanthate on the rat brain

    Having previously demonstrated that there is an approximately 20% loss of nerve cells in the basal ganglia (but no loss in the cortex) of rats following the administration of perphenazine enanthate for 12 mont...

    H. Pakkenberg, R. Fog in Psychopharmacologia (1974)

  12. No Access

    Article

    The long-term effect of perphenazine enanthate on the rat brain. Some metabolic and anatomical observations

    Perphenazine enanthate 3.4 mg/kg per injection, was administered subcutaneously to rats every second week over a period of a year, a total of 31 mg per animal being given. The animals were observed weekly and ...

    H. Pakkenberg, R. Fog, B. Nilakantan in Psychopharmacologia (1973)

  13. No Access

    Article

    Intrastriatal injection of quaternary butyrophenones and oxypertine: Neuroleptic effect in rats

    Bilateral intrastriatal microinjections in rat brains of quaternary neuroleptic drugs of the butyrophenone type (haloperidol, benperidol, floropipamide) and the indole type (oxypertine) antagonize amphetamine-...

    R. Fog, A. Randrup, H. Pakkenberg in Psychopharmacologia (1971)

  14. No Access

    Article

    Lesions in corpus striatum and cortex of rat brains and the effect on pharmacologically induced stereotyped, aggressive and cataleptic behaviour

    Large bilateral lesions affecting 30–90% of the corpus striatum inhibit stereotyped behaviour in rats injected subcutaneously with amphetamine, but do not prevent rage reactions induced by injection of a monoa...

    R. Fog, A. Randrup, H. Pakkenberg in Psychopharmacologia (1970)